Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Bordignon

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Human Gene Therapy|February 4, 2010
Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantationMaria Teresa Lupo-Stanghellini, Elena Provasi, Attilio Bondanza, et al.
Blood|March 22, 2003
Human T lymphocytes transduced by lentiviral vectors in the absence of TCR activation maintain an intact immune competenceSimona Cavalieri, Sabrina Cazzaniga, Massimo Geuna, et al.
Trends in Molecular Medicine|January 11, 2012
A dual role for genetically modified lymphocytes in cancer immunotherapyVincenzo Russo, Attilio Bondanza, Fabio Ciceri, et al.
Immunity|August 28, 2002
Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formationLoïc Dupré, Alessandro Aiuti, Sara Trifari, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 17, 2007
The suicide gene therapy challenge: how to improve a successful gene therapy approachChiara Bonini, Attilio Bondanza, Serena Kimi Perna, et al.
Blood|March 1, 2007
The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignanciesCatia Traversari, Sarah Marktel, Zulma Magnani, et al.
Blood|October 24, 2002
Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantationSarah Marktel, Zulma Magnani, Fabio Ciceri, et al.
Oncoimmunology|October 10, 2015
The tumor vessel targeting agent NGR-TNF controls the different stages of the tumorigenic process in transgenic mice by distinct mechanismsSimona Porcellini, Claudia Asperti, Barbara Valentinis, et al.
The Journal of Biological Chemistry|March 30, 2002
Absence of metabolic cross-correction in Tay-Sachs cells: implications for gene therapySabata Martino, Carla Emiliani, Brunella Tancini, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2004
Robust in vivo gene transfer into adult mammalian neural stem cells by lentiviral vectorsAntonella Consiglio, Angela Gritti, Diego Dolcetta, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Human Gene Therapy|February 4, 2010
Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantationMaria Teresa Lupo-Stanghellini, Elena Provasi, Attilio Bondanza, et al.
Blood|March 22, 2003
Human T lymphocytes transduced by lentiviral vectors in the absence of TCR activation maintain an intact immune competenceSimona Cavalieri, Sabrina Cazzaniga, Massimo Geuna, et al.
Trends in Molecular Medicine|January 11, 2012
A dual role for genetically modified lymphocytes in cancer immunotherapyVincenzo Russo, Attilio Bondanza, Fabio Ciceri, et al.
Immunity|August 28, 2002
Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formationLoïc Dupré, Alessandro Aiuti, Sara Trifari, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 17, 2007
The suicide gene therapy challenge: how to improve a successful gene therapy approachChiara Bonini, Attilio Bondanza, Serena Kimi Perna, et al.
Blood|March 1, 2007
The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignanciesCatia Traversari, Sarah Marktel, Zulma Magnani, et al.
Blood|October 24, 2002
Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantationSarah Marktel, Zulma Magnani, Fabio Ciceri, et al.
Oncoimmunology|October 10, 2015
The tumor vessel targeting agent NGR-TNF controls the different stages of the tumorigenic process in transgenic mice by distinct mechanismsSimona Porcellini, Claudia Asperti, Barbara Valentinis, et al.
The Journal of Biological Chemistry|March 30, 2002
Absence of metabolic cross-correction in Tay-Sachs cells: implications for gene therapySabata Martino, Carla Emiliani, Brunella Tancini, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2004
Robust in vivo gene transfer into adult mammalian neural stem cells by lentiviral vectorsAntonella Consiglio, Angela Gritti, Diego Dolcetta, et al.
Pageof 10